NCT05980416 2025-11-14
Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2
Elevation Oncology
Phase 1 Terminated
Clinical Trials
5 trialsNCT02564198 2021-08-17
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Eli Lilly and Company
Phase 1 Completed
NCT01285037 2018-02-20
A Study of LY2801653 in Advanced Cancer
Eli Lilly and Company
Phase 1 Completed
NCT00786383 2013-08-19
Study of IMC-1121B in Patients With Advanced Solid Tumors Not Responding To Standard Therapy
Eli Lilly and Company
Phase 1 Completed
NCT00793975 2013-08-19
Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy
Eli Lilly and Company
Phase 1 Completed